Resynchronisation Device Gains a Hearty Nod from the FDA

Published date : 09 May 2013
Article date : 06 May 2013

Bloomberg Business Week reports that Medtronic has been granted FDA approval for its Viva permanent implant device. The product is designed to resynchronise the beating of the heart and uses an algorithm to coordinate heart contractions, adjusting to the differing demands of the body as a patient undertakes their everyday lives. 

According to Medtronic, significantly more heart-failure patients responded to treatment via the Viva and they were 21% less likely to be hospitalised in the first year, than those with older devices.

Source: Michelle Fay Cortez, Reporter, Bloomberg Business Week, 06 May 2013 

Read the full article here.

Back to Listings

Share |

Find a Device

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.